CIK 0001433607 · Non-accelerated filer<br>Smaller reporting company
InspireMD, Inc.
Sign in to watch- Ticker
- NSPR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262123838
- Phone
- (888) 776-6804
- Business address
- 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, FL, 33126
- Former names
- Saguaro Resources, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-07 | BERMAN MICHAEL Director | Grant or award · Options to purchase common stock (right to buy) | +14,836 | 84,950 | ||
| 2025-01-07 | Arnold Kathryn Director | Grant or award | +32,491 | 247,531 | ||
| 2025-01-07 | Arnold Kathryn Director | Grant or award · Options to purchase common stock (right to buy) | +14,836 | 84,945 | ||
| 2024-06-24 | BERMAN MICHAEL Director | Option exercise | +61,249 | $1.38 | $85K | 183,746 |
| 2024-06-24 | BERMAN MICHAEL Director | Option exercise · Series H Warrant (right to buy) | −61,249 | 0 | ||
| 2024-06-05 | Stuka Paul Director | Option exercise | +87,500 | $1.38 | $121K | 336,034 |
| 2024-06-05 | Stuka Paul Director | Option exercise · Series H Warrant (right to buy) | −87,500 | 0 | ||
| 2024-05-28 | Kester Thomas J Director | Option exercise | +30,625 | $1.38 | $42K | 326,652 |
| 2024-05-28 | Kester Thomas J Director | Option exercise · Series H Warrant (right to buy) | −30,625 | 0 | ||
| 2024-05-28 | ROUBIN GARY S Director | Option exercise | +30,625 | $1.38 | $42K | 501,788 |
| 2024-05-28 | ROUBIN GARY S Director | Option exercise · Series H Warrant (right to buy) | −30,625 | 0 | ||
| 2024-01-23 | Kester Thomas J Director | Grant or award | +29,032 | 296,075 | ||
| 2024-01-23 | Kester Thomas J Director | Grant or award · Options to purchase common stock (right to buy) | +11,098 | 70,111 | ||
| 2024-01-23 | Gleason Shane Thomas Chief Commercial Officer | Grant or award | +238,625 | 514,365 | ||
| 2024-01-23 | Gleason Shane Thomas Chief Commercial Officer | Grant or award · Options to purchase common stock (right to buy) | +91,218 | 183,128 | ||
| 2024-01-23 | Stuka Paul Director | Grant or award | +43,548 | 311,548 | ||
| 2024-01-23 | Stuka Paul Director | Grant or award · Options to purchase common stock (right to buy) | +16,647 | 105,875 | ||
| 2024-01-23 | Verta Patrick EVP Clinical/Medical Affairs | Grant or award | +85,720 | 228,460 | ||
| 2024-01-23 | Verta Patrick EVP Clinical/Medical Affairs | Grant or award · Options to purchase common stock (right to buy) | +32,768 | 79,348 | ||
| 2024-01-23 | BERMAN MICHAEL Director | Grant or award | +29,032 | 232,042 |
Page 6 of 10 · 195 trades